Agenus Inc

XNAS:AGEN 4:00:00 PM EDT

3.47

+0.25 (+7.76%)

7:50:03 PM EDT: $3.45 -0.02 (-0.58%)

Market Cap (Intraday)	118.00M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	4.39

See more stats

Estimates Current Quarter

Revenue	$53.1 Million
Adjusted EPS	-$0.35

See more estimates

10-Day MA	$3.34
50-Day MA	$3.90
200-Day MA	$4.04

See more pivots

Agenus Inc Stock, XNAS:AGEN

3 Forbes Road, Lexington, Massachusetts 02421-7305

United States of America

Phone: +1.781.674.4400

Number of Employees: 316

http://www.agenusbio.com

Description

Agenus, Inc. is a clinical-stage company, which engages in the development and commercialization of technologies to treat cancers and infectious diseases. Its product pipeline includes Balstilimab, Zalifrelimab, AGEN1181, AGEN1327, AGEN2373, AGENt-797 and AGEN1777. The company was founded by Garo H. Armen and Pramod K. Srivastava on March 31, 1994 and is headquartered in Lexington, MA.